Clinical Trial Update: A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, pharmacodynamics, and safety of adding ETC-1002 to atorvastatin 80 mg in hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• ETC-1002 (bempedoic acid)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED